- Novel approach to treat neurodegenerative diseases by targeting fibrin-driven neuroinflammation was well-tolerated among healthy volunteers, with a clean hematological…
- Novel approach to treat neurodegenerative diseases by targeting fibrin-driven neuroinflammation was well-tolerated among healthy volunteers, with a clean hematological…
PHILADELPHIA, April 29, 2025 (GLOBE NEWSWIRE) -- Not One More Vet (NOMV), the leading nonprofit focused on mental health in…
PHILADELPHIA, April 29, 2025 (GLOBE NEWSWIRE) -- Not One More Vet (NOMV), the leading nonprofit focused on mental health in…
Award follows new contracts in Kansas and Washington and expands the company’s PASRR services for long-term care assessments to eight…
Award follows new contracts in Kansas and Washington and expands the company’s PASRR services for long-term care assessments to eight…
Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning chemotherapy-free treatment across autoimmune and cancer…
Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning chemotherapy-free treatment across autoimmune and cancer…
HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued…
HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued…